Grown Rogue International (GRUSF) Gains from Investment Securities (2009 - 2026)
Grown Rogue International (GRUSF) recorded quarterly Gains from Investment Securities of $200000.0 in Q1 2026, up 100.0% quarter-over-quarter from -$4.0 billion in Q4 2025, and up 2452.65% on a YoY basis from $7835.0 in Q1 2025.
Grown Rogue International (GRUSF) Gains from Investment Securities (2009 - 2026) Analysis & Trends
Grown Rogue International's Gains from Investment Securities history runs 12 years deep, the most recent figure standing at $200000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 2452.65% year-over-year to $200000.0; the TTM figure through Mar 2026 stood at $200000.0 (up 100.04% YoY), while the FY2025 annual figure was $1.5 million, up 350.54% from the prior year.
- Gains from Investment Securities was $200000.0 for Q1 2026 at Grown Rogue International, up from -$4.0 billion in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.7 billion in Q3 2025 to a low of -$4.0 billion in Q4 2025.
- Historically, Gains from Investment Securities has averaged -$135.9 million across 4 years, with a median of -$2740.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Gains from Investment Securities sank 36678.68% in 2025, then surged 2452.65% in 2026.
- A 4-year view of Gains from Investment Securities shows it stood at $8.7 million in 2023, then gained by 26.9% to $11.0 million in 2024, then tumbled by 36678.68% to -$4.0 billion in 2025, then surged by 100.0% to $200000.0 in 2026.
- The last three Gains from Investment Securities figures came in at $200000.0 (Q1 2026), -$4.0 billion (Q4 2025), and $2.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Grown Rogue International | - | - | 3.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | -4.02 Bn |
| Dec 31, 2025 | -4.02 Bn |
| Sep 30, 2025 | 2.74 Bn |
| Sep 30, 2025 | 2.74 Bn |
| Jun 30, 2025 | -6,547.00 |
| Jun 30, 2025 | -6,547.00 |
| Mar 31, 2025 | 7,835.00 |
| Mar 31, 2025 | 7,835.00 |
| Dec 31, 2024 | 11.00 Mn |
| Dec 31, 2024 | 11.00 Mn |
| Sep 30, 2024 | -499.00 Mn |
| Sep 30, 2024 | -499.00 Mn |
| Jun 30, 2024 | -5,132.00 |
| Jun 30, 2024 | -5,132.00 |
| Mar 31, 2024 | -2,740.00 |
| Mar 31, 2024 | -2,740.00 |
| Dec 31, 2023 | 8.67 Mn |
| Dec 31, 2023 | 8.67 Mn |